ReviewJournal of the American Heart Association2021
Maternal Heart Failure.
Review in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 52 citations in OpenAlex.
- Cardiovascular outcomes for Australian women with rheumatic heart disease during pregnancy: A retrospective linked data analysis, 2002-2017.Acta obstetricia et gynecologica Scandinavica · 2026Article
- Using a cardiac registry to highlight multidisciplinary care in pregnancy.Irish journal of medical science · 2026Article
- Revisiting the safety of short-term systemic corticosteroids.Biomedical journal · 2026Review
- A Prospective Observational Study to Assess the Impact of Focused Transthoracic Echocardiography on Diagnosis and Management in Patients Admitted to the Intensive Care Unit Post-Cesarean Section.Annals of cardiac anaesthesia · 2026Observational
- Acute cardiovascular complications of pregnancy.Case reports in women's health · 2025Article
- Impact of mode of delivery on maternal and fetal outcomes in pregnant patients with heart failure or pulmonary hypertension.American journal of preventive cardiology · 2025Article
- Society for Maternal-Fetal Medicine Consult Series #73: Diagnosis and management of right and left heart failure during pregnancy and postpartum.Pregnancy (Hoboken, N.J.) · 2025Article
- Cardiovascular-obstetric state-of-the-art review: pulmonary hypertension in pregnancy.Singapore medical journal · 2025Review
- Maternal heart failure: state-of-the-art review.Heart failure reviews · 2025Review
- Pregnancy and Postpartum Trends in Self-Measured Blood Pressure and Derived Indices: The BOSHI Study.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
- Navigating pregnancy with cardiovascular disease: pathophysiology, risk stratification, and maternal-fetal outcomes.Turkish journal of medical sciences · 2025Review
- Echocardiography for Management of Cardiovascular Disease in Pregnancy.Current cardiology reports · 2024Review
- Pregnancy outcomes among patients with complex congenital heart disease.NPJ cardiovascular health · 2024Article
- Sex difference in human diseases: mechanistic insights and clinical implications.Signal transduction and targeted therapy · 2024Review
- Article
- Preeclamptic heart failure - perioperative concerns and management: a narrative review.Perioperative medicine (London, England) · 2024Review
- The impact of vitamin D changes during pregnancy on the development of maternal adverse events: a random forest analysis.BMC pregnancy and childbirth · 2024Article
- Article
- The concentration of maternal sacubitril/valsartan transferred into human milk is negligible.Frontiers in public health · 2024Article
- Association between antenatal corticosteroid treatment and severe adverse events in pregnant women.BMC medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) remains the most common major cardiovascular complication arising in pregnancy and the postpartum period. Mothers who develop HF have been shown to experience an increased risk of death as well as a variety of adverse cardiac and obstetric outcomes. Recent studies have demonstrated that the risk to neonates is significant, with increased risks in perinatal morbidity and mortality, low Apgar scores, and prolonged neonatal intensive care unit stays. Information on the causal factors of HF can be used to predict risk and understand timing of onset, mortality, and morbidity. A variety of modifiable, nonmodifiable, and obstetric risk factors as well as comorbidities are known to increase a patient's likelihood of developing HF, and there are additional elements that are known to portend a poorer prognosis beyond the HF diagnosis. Multidisciplinary cardio-obstetric teams are becoming more prominent, and their existence will both benefit patients through direct care and increased awareness and educate clinicians and trainees on this patient population. Detection, access to care, insurance barriers to extended postpartum follow-up, and timely patient counseling are all areas where care for these women can be improved. Further data on maternal and fetal outcomes are necessary, with the formation of State Maternal Perinatal Quality Collaboratives paving the way for such advances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.